ALB and neoplasm: Affibodies (comprised of 58 amino acids) and albumin-binding domain-derived affinity proteins (ADAPTs; comprised of 46 amino acids) are two classes of polypeptides that fold into stable three-helix bundle structures and can be engineered for selective high-affinity binding to a variety of target structures, including cell surface receptors on tumor cells.